Clinical trialPhase 2Completed
Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma
Evaluation of the Effect of Ocoxin-Viusid® Nutritional Supplement in the Life Quality in Patients Diagnosed With Advanced Pancreatic Adenocarcinoma. Phase II
- Outcome
- Finished, no results posted
- Phase
- Phase 2
- Status
- Completed
- Study type
- Interventional
- Start
- 30 October 2018
- Expected end
- 20 January 2023
- Enrollment
- 30 participants
- Sites
- 1
- Primary outcomes
- Quality of Life: EORTC QLQ-C30
- Sponsor
- Industry
- Results posted
- No
- Last update
- 28 March 2023
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try